The medicinal marijuana facility in Albion is beginning production.
Ataraxia announced Monday it opened its doors to begin growing what the group believes to be the first round of medical cannabis in Illinois. Ataraxia, which is a Latin term meaning “a state of freedom from emotional disturbance and anxiety,” is cultivating genetics to address all of the conditions approved for treatment under the Compassionate Use of Medical Cannabis Pilot Program.
“We feel a profound sense of responsibility and share a deep commitment to making sure patients have the ability to benefit from a diverse product selection and targeted strains to help relieve their symptoms and live an overall improved quality of life,” says George Archos, chief executive officer of Ataraxia.
In a press release issued Monday, the company said Ataraxia’s 52,000-square-foot state-of-the-art clean-lab facility uses the most advanced technology and a proprietary nutrient feeding system to facilitate a consistent year-round grow cycle, ensuring the highest quality medicine for Illinois patients.
The group has done extensive research and has tapped the nations leaders in cannabis cultivation to bring “Cannabis Cup Winning Strains” to the Illinois market in addition to CBD-rich medical strains that are proven effective for many conditions including children with epilepsy. Ataraxia is working with local dispensaries throughout Illinois to distribute their Gold Leaf ™ product line, which will consist of oils, edibles, creams, vaporizer pens, a variety of premium flower and other treatment options.